產品系列 / 解決方案: IVD Solutions

GBC CellBio a2000 CTC System

Product Information Download

Download the GBC CellBio a2000 brochureDownload

PRODUCT INFORMATION

Patented iFiltration™ Technology — Made to Work

Engineered for precision, the CellBio a2000 uses patented iFiltration™ size-based separation to deliver intact circulating tumor cells (CTCs) and rare cells efficiently and reliably.

Key Highlights:

SPECIFICATION

Dimensions (W × D x H)400 x 225.5 x 202.9 mm
Weight9 kg
Power SupplyAC 100-240 V  50Hz/60Hz
Throughput2 samples (8 samples/day)
Display settingMask keyboardTouch screen operation
Display65565 Color LCD
Consumption< 50 W
Working environmentAmbient Temperature 5 – 40 °C  Relative Humidity < 80 %
CertificationRUO

ORDERING INFORMATION

Catalogue No.Product
4MGA2000GBC CellBio a2000 CTC System

Dynex DSX® Automated ELISA with Confidence

PRODUCT DESCRIPTION

The Dynex DSX® ELISA System is a fully automated, modular ELISA platform designed for medium-throughput laboratories that demand reliable walk-away operation. With four independent plate incubators, the system supports both 1 assay per strip and full 12-assay plates, helping manage workload and reduce labor demands.

Built-in features include reagent light protection (dark cover), barcode sample and plate tracking, “wash buffer low” and “waste full” alarms, fluid-level and tip detection, and error recovery capabilities. These validation and QC features safeguard assay integrity and reproducibility.

Compatible with all GB brand ELISA kits, it offers flexible sample loading, consistent plate temperature control, multiple wash buffer management, and clotted sample protection. Ideal for ELISA users in clinical labs, blood screening, and other institutions where throughput, accuracy, and automation are priorities.

FEATURE

Efficient, Dependable, and Economical

SPECIFICATION

Physical Specification
Dimensions (W x D x H)106 x 91 x 80 cm
Weight136 kg
Power Supply
Input PowerAC 100-240 V, 50/60 Hz, <800 VA
System Specifications
Number of Plates4
Sample Capacity96
Continuous Sample LoadingYes
Sample Tube Size10 mm – 16 mm diameter 40mm – 100 mm height
Number of ReagentsUp to 24 (25 mL tubes)
Number of Standard/Control Bottles33 (1.5 mL vials)
Assays per Plate1 assay per strip or up to 12 assays per plate
Dilution Wells CapacityUp to 192 deep-well strips (24 x 8)
Sample Tip Capacity432 (4 x 108)
Reagent Tip Capacity41 tips
Reader Specifications
Photometric Range0.000 – 3.000 OD
Spectral Range405 nm – 690 nm
Filter Slots6 wavelength
Washer Specifications
Manifold Configuration8-way
Programmable Volumes50 μL – 999 μL
Wash Buffer Capacity4 wash bottles at 2.0 L, with level-sensing
Incubator Specifications
Number of Incubators4
Temperature RangeRT + 7° C to 50° C (elevated incubator) RT + 5° C (ambient incubator)
Temperature Accuracy± 1° C
Shaking> 15 Hz periodic or continuous
Reagent Pipetting Specifications
Reagent Tip Size1,300 μL
Reagent Pipetting Volume25 μL – 1,000 μL
Sample Pipetting Specifications
Sample Tip Size300 μL
Sample Pipetting Volume10 μL – 250 μL single-shot 25 μL – 100  μL multi-shot

ORDERING INFORMATION

Catalogue No.Product
S00338Dynex DSX®

GBC CL i120 CLIA System

Product Information Download

Download GBC CL i120 Brochure (PDF)Download

SPECIFICATION

Dimensions430 (L) × 680 (W) × 620 (H) mm
Weight Net weight62 kg
Power voltage100V-240V～，50Hz/60Hz , 850VA
Ambient temperature10℃～30℃
Relative humidity≤85%，no condensation.
Sample typeHuman serum, plasma, whole blood, urine samples
PrincipleEnzymatic chemiluminescence or direct CLIA (AE)
Throughput120 tests/hour (max)
Time to First Result≤ 15 min
Sample position10 pcs
Sample position30 pcs
Solid Waste200 assay cups per container
Reagent refrigeration at reagent diskRefrigeration with a temperature of 2°C~8°C
Temperature stability37℃± 0.3℃
Liquid level detectionSupport
CertificationTFDA

PRODUCT INFORMATION

It is the fully automatic chemiluminescence analyzer, with below features.

ORDERING INFORMATION

Catalogue No.Product
4MGCLI120Chemiluminescence Analyzer  GBC CL i120

GBC Wato Microplate Washer

Product Information Download

Download GB Wato™ Microplate Washer Brochure (PDF)Download

PRODUCT INFORMATION

SPECIFICATION

Manifold8 way and 12 way manifold autoclavable
DispensingProgrammable up to 350 µL
Aspirating MethodContinuous through diaphragm pump while dispensing hence preventing overflow
Residual Volume< 2 µL
Waste Bottle1 (Capacity 2L) with audible alarm when the bottle is completely filled in with waste solution
Wash Bottle1 (Capacity 2L)
Rinse Bottle1 (Capacity 2L)
Display7″ inch LCD
Liquid Contact MaterialsSilicon, Stainless steel, Derline
Washing MethodPlate wash, Strip wash, Rinse and Prime
IncubatorSimultaneous incubation of 2 ELISA plates @ 37°C
TimerTwo independent programmable timers

ORDERING INFORMATION

Catalogue No.Product
4TWA01AGBC Wato Microplate Washer (Non-sterile)

GBC Rito ELISA Plate Analyzer

Product Information Download

Download GB Rito™ ELISA Plate Analyzer Brochure (PDF)Download

PRODUCT INFORMATION

SPECIFICATION

System TypeOpen
InterfaceTouch – 7″ inch Capacitive Touch LCD
Measuring Range0 – 4.0 OD
Linearity Range0 – 3.5 OD
Photometric Resolution0.001 OD
Photometric Accuracy±1 % for 0 to 3 OD & ± 2 % for 3 to 4 OD
LampLED light source
Optical Reading Channel8 Channels
Reading Speed10 sec single wavelength / 20 sec dual wavelength
Wavelength405 nm, 450 nm, 490 nm, 630 nm
Optional Wavelength1 Optional available upon request
Printer48 mm Onboard thermal printing
Memory200 Test & 50,000 Results
Analysis ModesAbsorbance, Cut-Off and Multi-Standard
InterfaceUSB, Wi-Fi and Ethernet
Dimension360 mm x 230 mm x 200 mm (LxWxH)
Weight5 kg

ORDERING INFORMATION

Catalogue No.Product
4TRI01AGBC Rito ELISA Plate Analyzer (Non-sterile)

GB SARS-CoV-2 Ab

PRODUCT DESCRIPTION

This product is a semi-quantitative ELISA reagent designed for detection of IgG and IgM antibodies to SARS-CoV-2 Spike or N protein in human serum or plasma. It uses a direct sandwich ELISA format on a 96-well plate. The test requires only 10 µL of sample and has a 105-minute incubation time with a 450 nm readout. Clinical validation shows 100% sensitivity and 100% specificity. Non-Reactive results indicate no detectable anti-SARS-CoV-2 antibodies; Reactive results signify presence of antibodies, to be interpreted alongside vaccination or infection history.

SPECIFICATION

Number of wells96
PrincipleDirect Sandwich
Assay formatSemi-Quantitative
Total incubation time105 minutes
Sample typeSerum or Plasma
Sample volume10 μL
Reading wavelength450nm
Storage2-8°C
CertificationRUO

PERFORMANCE

5 serum samples collected from RT-PCR confirmed COVID-19 patients were tested. 139 normal healthy patients with samples collected before COVID-19 outbreak were tested. The results are as follows：

The diagnostic sensitivity is 100%；The diagnostic specificity is 100%

Inter-assay precision CV< 10%Inter-assay precision CV< 20%

COMPARISON

Negative (n=89)Positive (n=5)
Company ACompany A
PosNegtotalPosNegtotal
GBCPos000415
Neg28789000
total28789415
SensitivityGBC100%
Company A80%
SpecificityGBC100%
Company A97.7%

ORDERING INFORMATION

Catalogue No.Product
4ECO001GB SARS-COV-2 Ab ELISA – 96T
4ECO002GB SARS-COV-2 Ab ELISA – 480T

GB SARS CoV-2 IgG

PRODUCT DESCRIPTION

This in vitro diagnostic ELISA assay is designed for qualitative detection of IgG antibodies specific for the SARS-CoV-2 spike protein in human serum. It uses an indirect ELISA format on a 96-well microplate, requiring 10 µL of sample, with a total incubation time of 105 minutes and a 450 nm read wavelength. Storage at 2-8°C. Negative (Non-Reactive) results indicate no detectable IgG; positive (Reactive) results suggest presence of spike-protein IgG antibodies, to be interpreted alongside vaccine or infection history. 

SPECIFICATION

Number of wells96
PrincipleIndirect
Assay formatQualitative
Total incubation time105 minutes
Sample typeSerum
Sample volume10 μL
Reading wavelength450nm
Storage2-8°C
CertificationRUO

PERFORMANCE

58 normal healthy patients with samples collected before COVID-19 outbreak were tested. The results are as follows：

The diagnostic sensitivity is 100%；The diagnostic specificity is 96.55%

PERFORMANCETest PositiveTest Negative
Confirmed Positive058
Confirmed Negative256

ORDERING INFORMATION

Catalogue No.Product
4ECO101EGB SARS-CoV-2 IgG – 96T

HEPAVASE MA-96 (TMB) (Anti-HAV IgM)

PRODUCT DESCRIPTION

This product is designed as an IgM capture ELISA for detection of acute Hepatitis A virus (HAV) infection. The solid phase is coated with capture antibodies specific for HAV IgM, while the liquid phase includes purified peroxidase-conjugated antibodies. It is optimized to detect early infection through IgM antibodies.

SPECIFICATION

Number of wells96
PrincipleIgM Capture
Assay formatQualitative
Total incubation time150 minutes
Sample typeSerum / Plasma
Sample volume10 μL
Reading wavelength450nm
Storage2-8°C
CertificationTFDA

PERFORMANCE

1570 hospitalized patients were tested. The results are as follows：

The diagnostic sensitivity is 98%；The diagnostic specificity is 100%

Inter-assay precision CV< 20%Intra-assay precision CV< 15%

ORDERING INFORMATION

Catalogue No.Product
4AME3HEPAVASE MA-96 (TMB)

HEPAVASE A-96 (TMB) (Anti-HAV Antibody)

PRODUCT DESCRIPTION

This product is a competitive ELISA reagent designed for qualitative detection of Anti-HAV antibodies in human serum or plasma. With a 10 µL sample volume, 450 nm read wavelength, and 150-minute incubation time, it ensures sensitive and specific results (99.8% sensitivity, 99.5% specificity) with Inter-assay CV <25% and Intra-assay CV <20%. Certified by TFDA, it is reliable, user-friendly, and suited for clinical laboratory use.

SPECIFICATION

Number of wells96
PrincipleCompetitive
Assay formatQualitative
Total incubation time150 minutes
Sample typeSerum / Plasma
Sample volume10 μL
Reading wavelength450nm
Storage2-8°C
CertificationTFDA

PERFORMANCE

1541 hospitalized patients were tested. The results are as follows：

The diagnostic sensitivity is 99.8%；The diagnostic specificity is 99.5%

Inter-assay precision CV< 25%Intra-assay precision CV< 20%

ORDERING INFORMATION

Catalogue No.Product
4AGE3GB HEPAVASE A-96 (TMB)

ANTICORASE MB-96 (TMB) (Anti-HBc IgM)

PRODUCT DESCRIPTION

This product is an IgM capture ELISA assay for qualitative detection of Anti-HBc IgM in human serum or plasma, indicative of acute hepatitis B virus (HBV) infection. It requires only 5 µL sample volume, with a 150-minute incubation and 450 nm read wavelength. Tested in 1,541 hospitalized patients, showing 96.1% sensitivity and 100% specificity. Certified by TFDA and CE; storage at 2-8°C.

SPECIFICATION

✱Notified body: 0344

Number of wells96
PrincipleIgM Capture
Assay formatQualitative
Total incubation time150 minutes
Sample typeSerum / Plasma
Sample volume5 μL
Reading wavelength450nm
Storage2-8°C
CertificationTFDA / CE marked ✱

PERFORMANCE

1541 hospitalized patients were tested. The results are as follows：

The diagnostic sensitivity is 96.1%；The diagnostic specificity is 100%

Inter-assay precision CV< 25%Intra-assay precision CV< 20%

ORDERING INFORMATION

Catalogue No.Product
4CME3ANTICORASE MB-96 (TMB)